[
  {
    "ts": null,
    "headline": "Here's Why You Should Hold DexCom Stock in Your Portfolio for Now",
    "summary": "DXCM's strong Q3 growth, expanding CGM coverage and innovation-driven momentum position it for sustained adoption despite rising competition.",
    "url": "https://finnhub.io/api/news?id=a99c54f94a479689fb3e85f295569b0f7be7e52f5d8ffe6fff8c1e4edd3054c5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762883040,
      "headline": "Here's Why You Should Hold DexCom Stock in Your Portfolio for Now",
      "id": 137449941,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "DXCM's strong Q3 growth, expanding CGM coverage and innovation-driven momentum position it for sustained adoption despite rising competition.",
      "url": "https://finnhub.io/api/news?id=a99c54f94a479689fb3e85f295569b0f7be7e52f5d8ffe6fff8c1e4edd3054c5"
    }
  },
  {
    "ts": null,
    "headline": "Medtronic: Possible Earnings Beat Incoming But Still Overvalued",
    "summary": "Medtronic plc offers reliable dividends and steady cash flow, but limited growth prospects make MDT stock a cautious hold. Click for my MDT earnings preview.",
    "url": "https://finnhub.io/api/news?id=728b6f2f10d052e542a15011fdef72ee2f6ff39e49f7cc4e571f06743480c9ec",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762877094,
      "headline": "Medtronic: Possible Earnings Beat Incoming But Still Overvalued",
      "id": 137450342,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1481143570/image_1481143570.jpg?io=getty-c-w1536",
      "related": "BSX",
      "source": "SeekingAlpha",
      "summary": "Medtronic plc offers reliable dividends and steady cash flow, but limited growth prospects make MDT stock a cautious hold. Click for my MDT earnings preview.",
      "url": "https://finnhub.io/api/news?id=728b6f2f10d052e542a15011fdef72ee2f6ff39e49f7cc4e571f06743480c9ec"
    }
  },
  {
    "ts": null,
    "headline": "Brokers Suggest Investing in Boston Scientific (BSX): Read This Before Placing a Bet",
    "summary": "Based on the average brokerage recommendation (ABR), Boston Scientific (BSX) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?",
    "url": "https://finnhub.io/api/news?id=4bee2794d1162c86b93e2014f8290190c6af40eb4da7ba87d841542dbdfb2f40",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762871402,
      "headline": "Brokers Suggest Investing in Boston Scientific (BSX): Read This Before Placing a Bet",
      "id": 137448913,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Based on the average brokerage recommendation (ABR), Boston Scientific (BSX) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?",
      "url": "https://finnhub.io/api/news?id=4bee2794d1162c86b93e2014f8290190c6af40eb4da7ba87d841542dbdfb2f40"
    }
  },
  {
    "ts": null,
    "headline": "If You Invested $1000 in Boston Scientific a Decade Ago, This is How Much It'd Be Worth Now",
    "summary": "Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.",
    "url": "https://finnhub.io/api/news?id=49b92b15375604eaabe5f0758ca5fefec722d46275515084b1cdade93168eb49",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762867802,
      "headline": "If You Invested $1000 in Boston Scientific a Decade Ago, This is How Much It'd Be Worth Now",
      "id": 137448914,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.",
      "url": "https://finnhub.io/api/news?id=49b92b15375604eaabe5f0758ca5fefec722d46275515084b1cdade93168eb49"
    }
  },
  {
    "ts": null,
    "headline": "Penumbra Stock Up Post Q3 Earnings & Revenue Beat, Margins Expand",
    "summary": "PEN's Q3 results impress with double-digit sales growth, margin expansion and a strong 20% stock surge after its earnings beat.",
    "url": "https://finnhub.io/api/news?id=f10c563ff67ea6846aeebd9462ad820eedb5b9298e5825703843887044a1d608",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762865700,
      "headline": "Penumbra Stock Up Post Q3 Earnings & Revenue Beat, Margins Expand",
      "id": 137448915,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "PEN's Q3 results impress with double-digit sales growth, margin expansion and a strong 20% stock surge after its earnings beat.",
      "url": "https://finnhub.io/api/news?id=f10c563ff67ea6846aeebd9462ad820eedb5b9298e5825703843887044a1d608"
    }
  },
  {
    "ts": null,
    "headline": "VCYT Stock Gains on Q3 Earnings and Revenue Beat, '25 View Up",
    "summary": "Veracyte surges 27.5% after Q3 earnings and revenues beat estimates, driven by strong Decipher and Afirma test growth.",
    "url": "https://finnhub.io/api/news?id=665b29377782feebd6fdccbea72471b6e82448f4648ca6f1d1ad6cfe71f7c4ed",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762863960,
      "headline": "VCYT Stock Gains on Q3 Earnings and Revenue Beat, '25 View Up",
      "id": 137448916,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Veracyte surges 27.5% after Q3 earnings and revenues beat estimates, driven by strong Decipher and Afirma test growth.",
      "url": "https://finnhub.io/api/news?id=665b29377782feebd6fdccbea72471b6e82448f4648ca6f1d1ad6cfe71f7c4ed"
    }
  },
  {
    "ts": null,
    "headline": "1 of Wall Street’s Favorite Stock on Our Watchlist and 2 We Ignore",
    "summary": "Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.",
    "url": "https://finnhub.io/api/news?id=3cf31e24835c7c2fbaa94c1689913728c69fc89392ff0da098049e0a1798612b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762835898,
      "headline": "1 of Wall Street’s Favorite Stock on Our Watchlist and 2 We Ignore",
      "id": 137448917,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.",
      "url": "https://finnhub.io/api/news?id=3cf31e24835c7c2fbaa94c1689913728c69fc89392ff0da098049e0a1798612b"
    }
  }
]